A novel recent finding was that the absence of CLDN16 in ameloblasts explains the clinical finding of amelogenesis imperfecta in FHHNC patients and mice with CLDN16 deficiency (45). This evidence concerns the gene CLDN16 and familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis.